HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CD8+ gamma-delta TCR+ and CD4+ T cells produce IFN-γ at 5-7 days after yellow fever vaccination in Indian rhesus macaques, before the induction of classical antigen-specific T cell responses.

Abstract
The yellow fever 17D (YF-17D) vaccine is one of the most efficacious vaccines developed to date. Interestingly, vaccination with YF-17D induces IFN-γ production early after vaccination (days 5-7) before the development of classical antigen-specific CD8(+) and CD4(+) T cell responses. Here we investigated the cellular source of this early IFN-γ production. At days 5 and 7 post-vaccination activated CD8(+) gamma-delta TCR T cells produced IFN-γ and TNF-α. Activated CD4(+) T cells produced IFN-γ and TNF-α at day 7 post-vaccination. This early IFN-γ production was also induced after vaccination with recombinant YF-17D (rYF-17D), but was not observed after recombinant Adenovirus type 5 (rAd5) vaccination. Early IFN-γ production, therefore, might be an important aspect of yellow fever vaccination.
AuthorsPatrícia C C Neves, Richard A Rudersdorf, Ricardo Galler, Myrna C Bonaldo, Marlon Gilsepp Veloso de Santana, Philip A Mudd, Maurício A Martins, Eva G Rakasz, Nancy A Wilson, David I Watkins
JournalVaccine (Vaccine) Vol. 28 Issue 51 Pg. 8183-8 (Nov 29 2010) ISSN: 1873-2518 [Electronic] Netherlands
PMID20939995 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2010 Elsevier Ltd. All rights reserved.
Chemical References
  • Antigens, Viral
  • Receptors, Antigen, T-Cell, gamma-delta
  • Yellow Fever Vaccine
  • Interferon-gamma
Topics
  • Animals
  • Antigens, Viral (immunology)
  • CD4-Positive T-Lymphocytes (immunology)
  • CD8-Positive T-Lymphocytes (chemistry, immunology)
  • Interferon-gamma (metabolism)
  • Macaca mulatta
  • Receptors, Antigen, T-Cell, gamma-delta (analysis)
  • T-Lymphocyte Subsets (chemistry, immunology)
  • Yellow Fever Vaccine (administration & dosage, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: